Processa Pharmaceuticals Inc [NASDAQ: PCSA] jumped around 16769999.76 points on Friday, while shares priced at $16770000.0 at the close of the session, up 149233904%.
Compared to the average trading volume of 16.77M shares, PCSA reached a trading volume of 149233904 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Processa Pharmaceuticals Inc [PCSA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PCSA shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PCSA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Processa Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 25, 2024.
The Price to Book ratio for the last quarter was 0.48, with the Price to Cash per share for the same quarter was set at 0.11.
How has PCSA stock performed recently?
Processa Pharmaceuticals Inc [PCSA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.03. With this latest performance, PCSA shares gained by 26.12% in over the last four-week period, additionally sinking by -69.22% over the last 6 months – not to mention a drop of -63.78% in the past year of trading.
Processa Pharmaceuticals Inc [PCSA]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -162.10%, with Return on Assets sitting at -162.10%.
Earnings analysis for Processa Pharmaceuticals Inc [PCSA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PCSA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Processa Pharmaceuticals Inc go to 42.13%.
Insider trade positions for Processa Pharmaceuticals Inc [PCSA]
There are presently around $0.65%, or 0.67%% of PCSA stock, in the hands of institutional investors.
